Comparative expression of matrix metalloproteinases in low-grade mucoepidermoid carcinoma and typical lung cancer

Oncology Letters

Volumn 2, Issue 6, 2011, Pages 1269-1273

  Fan, Jiang ^a   Wu, Feng Ying ^a   Wang, Lei ^b   Jiang, Ge Ning ^a   Gao, Wen ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Matrix metalloproteinases; Mucoepidermoid carcinoma; Non small cell lung cancer

Indexed keywords

GELATINASE A; GELATINASE B; MATRILYSIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; COMPARATIVE STUDY; ENZYME ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MUCOEPIDERMOID TUMOR; PROTEIN EXPRESSION;

EID: 80052742722     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol_2011.387     Document Type: Article

References (18)

1. Molina JR, Aubry MC, Lewis JE, et al: Primary salivary gland-type lung cancer: spectrum of clinical presentation, histopathologic and prognostic factors. Cancer 110: 2253-2259, 2007.
2. Heitmiller RF, Mathisen DJ, Ferry JA, Mark EJ and Grillo HC: Mucoepidermoid lung tumors. Ann Thorac Surg 47: 394-399, 1989.
3. Chin CH, Huang CC, Lin MC, Chao TY and Liu SF: Prognostic factors of tracheobronchial mucoepidermoid carcinoma-15 years experience. Respirology 13: 275-280, 2008.
4. Yang KY, Chen YM, Huang MH and Perng RP: Revisit of primary malignant neoplasms of the trachea: clinical characteristics and survival analysis. Jpn J Clin Oncol 27: 305-309, 1997.
5. Lal DR, Clark I, Shalkow J, et al: Primary epithelial lung malignancies in the pediatric population. Pediatr Blood Cancer 45: 683-686, 2005.
6. Torres AM and Ryckman FC: Childhood tracheobronchial mucoepidermoid carcinoma: a case report and review of the literature. J Pediatr Surg 23: 367-370, 1988.
7. Passlick B, Sienel W, Seen-Hibler R, et al: Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer. Clin Cancer Res 6: 3944-3948, 2000.
8. Gonzalez N, Rodriguez N, Tripari J, et al: RT-PCR comparative study of viral load levels in the HIV positive population in Puerto Rico before and after protease inhibitor regimen implanted. Bol Asoc Med P R 90: 16-20, 1998.
9. Kodate M, Kasai T, Hashimoto H, Yasumoto K, Iwata Y and Manabe H: Expression of matrix metalloproteinase (gelatinase) in T1 adenocarcinoma of the lung. Pathol Int 47: 461-469, 1997.
10. Brown PD, Bloxidge RE, Stuart NS, Gatter KC and Carmichael J: Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma. J Natl Cancer Inst 85: 574-578, 1993.
11. Yousem SA and Hochholzer L: Mucoepidermoid tumors of the lung. Cancer 60: 1346-1352, 1987.
12. Moran CA, Suster S and Koss MN: Primary adenoid cystic carcinoma of the lung. A clinicopathologic and immunohistochemical study of 16 cases. Cancer 73: 1390-1397, 1994.
13. Minna JD, Roth JA and Gazdar AF: Focus on lung cancer. Cancer Cell 1: 49-52, 2002.
14. Hoikkala S, Paakko P, Soini Y, Makitaro R, Kinnula V and Turpeenniemi-Hujanen T: Tissue MMP-2 and MMP-9 are better prognostic factors than serum MMP-2/TIMP-2-complex or TIMP-1 in stage I-III lung carcinoma. Cancer Lett 236: 125-132, 2006.
15. Turnbull AD, Huvos AG, Goodner JT and Foote FW, Jr.: Mucoepidermoid tumors of bronchial glands. Cancer 28: 539-544, 1971.
16. Chambers AF and Matrisian LM: Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89: 1260-1270, 1997.
17. Westermarck J and Kahari VM: Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13: 781-792, 1999.
18. Sienel W, Hellers J, Morresi-Hauf A, et al: Prognostic impact of matrix metalloproteinase-9 in operable non-small cell lung cancer. Int J Cancer 103: 647-651, 2003.